Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

Clinical trial NCT06730477 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06730477
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Lung Adenocarcinoma EGFR Activating Mutation

Start date: 2021-01-01
Primary completion: 2026-12-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.